1
|
Budama-Kilinc Y, Kurtur OB, Gok B, Cakmakci N, Kecel-Gunduz S, Unel NM, Ozturk TK. Use of Immunoglobulin Y Antibodies: Biosensor-based Diagnostic Systems and Prophylactic and Therapeutic Drug Delivery Systems for Viral Respiratory Diseases. Curr Top Med Chem 2024; 24:973-985. [PMID: 38561616 DOI: 10.2174/0115680266289898240322073258] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/28/2023] [Revised: 03/02/2024] [Accepted: 03/11/2024] [Indexed: 04/04/2024]
Abstract
Respiratory viruses have caused many pandemics from past to present and are among the top global public health problems due to their rate of spread. The recently experienced COVID-19 pandemic has led to an understanding of the importance of rapid diagnostic tests to prevent epidemics and the difficulties of developing new vaccines. On the other hand, the emergence of resistance to existing antiviral drugs during the treatment process poses a major problem for society and global health systems. Therefore, there is a need for new approaches for the diagnosis, prophylaxis, and treatment of existing or new types of respiratory viruses. Immunoglobulin Y antibodies (IgYs) obtained from the yolk of poultry eggs have significant advantages, such as high production volumes, low production costs, and high selectivity, which enable the development of innovative and strategic products. Especially in diagnosing respiratory viruses, antibody-based biosensors in which these antibodies are integrated have the potential to provide superiority in making rapid and accurate diagnosis as a practical diagnostic tool. This review article aims to provide information on using IgY antibodies in diagnostic, prophylactic, and therapeutic applications for respiratory viruses and to provide a perspective for future innovative applications.
Collapse
Affiliation(s)
- Yasemin Budama-Kilinc
- Department of Bioengineering, Faculty of Chemical and Metallurgical Engineering, Yildiz Technical University, Istanbul, Turkiye
- Health Biotechnology Joint Research and Application Center of Excellence, Istanbul, Turkey
| | - Ozan Baris Kurtur
- Graduate School of Natural and Applied Science, Yildiz Technical University, Istanbul, Turkey
| | - Bahar Gok
- Graduate School of Natural and Applied Science, Yildiz Technical University, Istanbul, Turkey
| | - Nisanur Cakmakci
- Graduate School of Natural and Applied Science, Yildiz Technical University, Istanbul, Turkey
| | - Serda Kecel-Gunduz
- Physics Department, Faculty of Science, Istanbul University, Istanbul, Turkiye
| | - Necdet Mehmet Unel
- Department of Genetics and Bioengineering, Faculty of Engineering and Architecture, Kastamonu University, Plantomics Research Laboratory, Kastamonu, Turkiye
- Research and Application Center, Kastamonu University, Kastamonu, Turkiye
| | | |
Collapse
|
2
|
Alginates Combined with Natural Polymers as Valuable Drug Delivery Platforms. Mar Drugs 2022; 21:md21010011. [PMID: 36662184 PMCID: PMC9861938 DOI: 10.3390/md21010011] [Citation(s) in RCA: 7] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/21/2022] [Revised: 12/19/2022] [Accepted: 12/20/2022] [Indexed: 12/28/2022] Open
Abstract
Alginates (ALG) have been used in biomedical and pharmaceutical technologies for decades. ALG are natural polymers occurring in brown algae and feature multiple advantages, including biocompatibility, low toxicity and mucoadhesiveness. Moreover, ALG demonstrate biological activities per se, including anti-hyperlipidemic, antimicrobial, anti-reflux, immunomodulatory or anti-inflammatory activities. ALG are characterized by gelling ability, one of the most frequently utilized properties in the drug form design. ALG have numerous applications in pharmaceutical technology that include micro- and nanoparticles, tablets, mucoadhesive dosage forms, wound dressings and films. However, there are some shortcomings, which impede the development of modified-release dosage forms or formulations with adequate mechanical strength based on pure ALG. Other natural polymers combined with ALG create great potential as drug carriers, improving limitations of ALG matrices. Therefore, in this paper, ALG blends with pectins, chitosan, gelatin, and carrageenans were critically reviewed.
Collapse
|
3
|
Yadav N, Mudgal D, Anand R, Jindal S, Mishra V. Recent development in nanoencapsulation and delivery of natural bioactives through chitosan scaffolds for various biological applications. Int J Biol Macromol 2022; 220:537-572. [PMID: 35987359 DOI: 10.1016/j.ijbiomac.2022.08.098] [Citation(s) in RCA: 14] [Impact Index Per Article: 7.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/17/2022] [Revised: 08/13/2022] [Accepted: 08/13/2022] [Indexed: 12/19/2022]
Abstract
Nowadays, nano/micro-encapsulation as a pioneering technique may significantly improve the bioavailability and durability of Natural bioactives. For this purpose, chitosan as a bioactive cationic natural polysaccharide has been frequently used as a carrier because of its distinct chemical and biological properties, including polycationic nature, biocompatibility, and biodegradability. Moreover, polysaccharide-based nano/micro-formulations are a new and extensive trend in scientific research and development in the disciplines of biomedicine, bioorganic/ medicinal chemistry, pharmaceutics, agrochemistry, and the food industry. It promises a new paradigm in drug delivery systems and nanocarrier formulations. This review aims to summarize current developments in approaches for designing innovative chitosan micro/nano-matrix, with an emphasis on the encapsulation of natural bioactives. The special emphasis led to a detailed integrative scientific achievement of the functionalities and abilities for encapsulating natural bioactives and mechanisms regulated in vitro/in vivo release in various biological/physiological environments.
Collapse
Affiliation(s)
- Nisha Yadav
- Amity Institute of Click Chemistry Research and Studies, Amity University Noida, UP-201313, India
| | - Deeksha Mudgal
- Amity Institute of Click Chemistry Research and Studies, Amity University Noida, UP-201313, India
| | - Ritesh Anand
- Amity Institute of Click Chemistry Research and Studies, Amity University Noida, UP-201313, India
| | - Simran Jindal
- Amity Institute of Click Chemistry Research and Studies, Amity University Noida, UP-201313, India
| | - Vivek Mishra
- Amity Institute of Click Chemistry Research and Studies, Amity University Noida, UP-201313, India.
| |
Collapse
|
4
|
Alginate-based nanocarriers for the delivery and controlled-release of bioactive compounds. Adv Colloid Interface Sci 2022; 307:102744. [PMID: 35878506 DOI: 10.1016/j.cis.2022.102744] [Citation(s) in RCA: 34] [Impact Index Per Article: 17.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/02/2022] [Revised: 07/16/2022] [Accepted: 07/17/2022] [Indexed: 11/22/2022]
Abstract
Alginate-based nanocarriers are propitious vehicles used for the delivery of bioactive compounds (bioactives). In this area, calcium alginate and sodium alginate are the most promising wall materials because they are nontoxic, comparatively cheap, simple in production, biocompatible and biodegradable. In this review, we have highlighted different alginate-based nanocarriers such as nanoparticles, nanofibers, nanoemulsions, nanocomplexes, and nanohydrogels; also entrapment of different bioactives within alginate nanocarriers and their bioavailability in the gastric environment has been comprehensively discussed. Being biopolymers, alginates can be exploited as emulsifiers/ encapsulants for entrapment and delivery of different bioactives such as vitamins, minerals, essential fatty acids, peptides, essential oils, bioactive oils, polyphenols and carotenoids. Furthermore, the use of alginate-based nanocarriers in combination with other polysaccharides/ emulsifiers was recognized as the most effective and favorable approach for the protection, delivery and sustained release of bioactives.
Collapse
|
5
|
Assessment of the effect of polymeric nanoparticles on storage and stability of blood products (red blood cells, plasma, and platelet). Polym Bull (Berl) 2022. [DOI: 10.1007/s00289-022-04147-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
6
|
Karthikeyan M, Indhuprakash ST, Gopal G, Ambi SV, Krishnan UM, Diraviyam T. Passive immunotherapy using chicken egg yolk antibody (IgY) against diarrheagenic E. coli: A systematic review and meta-analysis. Int Immunopharmacol 2021; 102:108381. [PMID: 34810126 DOI: 10.1016/j.intimp.2021.108381] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/25/2021] [Revised: 10/25/2021] [Accepted: 11/15/2021] [Indexed: 11/19/2022]
Abstract
BACKGROUND Animal diarrhea due to diarrheagenic Escherichia coli (E. coli) has been a major concern in the field of livestock farming leading to a severe loss of domesticated animals. This systematic review aims to analyze medical shreds of evidence available in the literature and to discover the effect of IgY in treatment and protection against E. coli diarrhea. METHODS AND RESULTS Research reports that aimed to evaluate the effect of IgY against E. coli diarrhea were searched and collected from several databases (Science Direct, Springer link, Wiley, T&F). The collected studies were screened based on the inclusion criteria. 19 studies were identified and included in the meta-analysis. The pooled relative risk ratios were calculated for the studies and found to be statistically significant to support the therapeutic effect of IgY against E. coli diarrhea but the 95% confidence interval of a majority of studies includes a relative risk of 1. This variability between the effect of IgY in the overall estimate and individual studies accounts due to the presence of methodological heterogeneity. In addition, subgroup analysis revealed the grounds for heterogeneity. CONCLUSIONS This systematic review and meta-analysis provide concrete evidence for the favorable effect of IgY as a prophylactic and therapeutic modality against E. coli diarrhea. Yet, more research pieces of evidence with standardized animal studies aimed to utilize IgY against E. coli are vital. Further studies and trials on human subjects could open new perspectives in the application IgY as a therapeutic agent.
Collapse
Affiliation(s)
- Mukunthan Karthikeyan
- Department of Biotechnology, School of Chemical & Biotechnology, SASTRA Deemed-to-be-University, Thanjavur 613401, Tamil Nadu, India
| | - Srichandrasekar Thuthikkadu Indhuprakash
- Centre for Research in Infectious Diseases (CRID), Department of Bioengineering, School of Chemical & Biotechnology, SASTRA Deemed-to-be-University, Thanjavur 613401, Tamil Nadu, India
| | - Gayathri Gopal
- Centre for Research in Infectious Diseases (CRID), Department of Bioengineering, School of Chemical & Biotechnology, SASTRA Deemed-to-be-University, Thanjavur 613401, Tamil Nadu, India
| | - Senthil Visaga Ambi
- Centre for Research in Infectious Diseases (CRID), Department of Bioengineering, School of Chemical & Biotechnology, SASTRA Deemed-to-be-University, Thanjavur 613401, Tamil Nadu, India
| | - Uma Maheswari Krishnan
- Centre for Nanotechnology & Advanced Biomaterials (CeNTAB), School of Chemical & Biotechnology and School of Arts, Science & Humanities, SASTRA Deemed-to-be-University, Thanjavur 613401, Tamil Nadu, India
| | - Thirumalai Diraviyam
- Centre for Research in Infectious Diseases (CRID), Department of Bioengineering, School of Chemical & Biotechnology, SASTRA Deemed-to-be-University, Thanjavur 613401, Tamil Nadu, India.
| |
Collapse
|
7
|
Avendaño C, Vidal S, Villamizar-Sarmiento MG, Guzmán M, Hidalgo H, Lapierre L, Valenzuela C, Sáenz L. Encapsulation of Cochleates Derived from Salmonella Infantis with Biopolymers to Develop a Potential Oral Poultry Vaccine. Polymers (Basel) 2021; 13:3426. [PMID: 34641241 PMCID: PMC8512329 DOI: 10.3390/polym13193426] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/13/2021] [Accepted: 09/28/2021] [Indexed: 12/31/2022] Open
Abstract
The aim of this study was to develop and characterize Salmonellaenterica serovar Infantis (S. Infantis) cochleates protected by encapsulation technology as a potential vaccine and to determine its safety in pullets. Cochleates were encapsulated by two technologies, spray drying and ionotropic gelation at different concentrations (0-15% v/v), and were characterized by physicochemical properties, protein content and Fourier Transform Infrared Spectroscopy (FTIR). The cochleates were white liquid suspensions with tubular shapes and a protein content of 1.0-2.1 mg/mL. After encapsulation by spray drying, microparticles ranged in size from 10.4-16.9 µm, were spherical in shape, and the protein content was 0.7-1.8 mg/g. After encapsulation by ionotropic gelation, beads ranged in size from 1620-1950 µm and were spherical in shape with a protein content of 1.0-2.5 mg/g. FTIR analysis indicated that both encapsulation processes were efficient. The cochleates encapsulated by ionotropic gelation were then tested for safety in pullets. No ill effect on the health of animals was observed upon physical or postmortem examination. In conclusion, this study was the first step in developing a potential oral S. Infantis vaccine safe for poultry using a novel cochleate encapsulation technology. Future studies are needed to determine the effectiveness of the vaccine.
Collapse
Affiliation(s)
- Constanza Avendaño
- Faculty of Veterinary Sciences, University of Chile, Santiago 8820808, Chile; (C.A.); (S.V.); (M.G.V.-S.); (M.G.); (H.H.); (L.L.)
| | - Sonia Vidal
- Faculty of Veterinary Sciences, University of Chile, Santiago 8820808, Chile; (C.A.); (S.V.); (M.G.V.-S.); (M.G.); (H.H.); (L.L.)
| | - María Gabriela Villamizar-Sarmiento
- Faculty of Veterinary Sciences, University of Chile, Santiago 8820808, Chile; (C.A.); (S.V.); (M.G.V.-S.); (M.G.); (H.H.); (L.L.)
- Department of Sciences and Pharmaceutical Technology, University of Chile, Santiago 8380494, Chile
| | - Miguel Guzmán
- Faculty of Veterinary Sciences, University of Chile, Santiago 8820808, Chile; (C.A.); (S.V.); (M.G.V.-S.); (M.G.); (H.H.); (L.L.)
- Nucleus of Applied Research in Veterinary and Agronomic Sciences, NIAVA, Faculty of Veterinary Medicine and Agronomy, Universidad de las Américas, Santiago 9250000, Chile
| | - Héctor Hidalgo
- Faculty of Veterinary Sciences, University of Chile, Santiago 8820808, Chile; (C.A.); (S.V.); (M.G.V.-S.); (M.G.); (H.H.); (L.L.)
| | - Lisette Lapierre
- Faculty of Veterinary Sciences, University of Chile, Santiago 8820808, Chile; (C.A.); (S.V.); (M.G.V.-S.); (M.G.); (H.H.); (L.L.)
| | - Carolina Valenzuela
- Faculty of Veterinary Sciences, University of Chile, Santiago 8820808, Chile; (C.A.); (S.V.); (M.G.V.-S.); (M.G.); (H.H.); (L.L.)
| | - Leonardo Sáenz
- Faculty of Veterinary Sciences, University of Chile, Santiago 8820808, Chile; (C.A.); (S.V.); (M.G.V.-S.); (M.G.); (H.H.); (L.L.)
| |
Collapse
|
8
|
Zhang J, Li HH, Chen YF, Chen LH, Tang HG, Kong FB, Yao YX, Liu XM, Lan Q, Yu XF. Microencapsulation of immunoglobulin Y: optimization with response surface morphology and controlled release during simulated gastrointestinal digestion. J Zhejiang Univ Sci B 2021; 21:611-627. [PMID: 32748577 DOI: 10.1631/jzus.b2000172] [Citation(s) in RCA: 6] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/11/2023]
Abstract
Immunoglobulin Y (IgY) is an effective orally administered antibody used to protect against various intestinal pathogens, but which cannot tolerate the acidic gastric environment. In this study, IgY was microencapsulated by alginate (ALG) and coated with chitooligosaccharide (COS). A response surface methodology was used to optimize the formulation, and a simulated gastrointestinal (GI) digestion (SGID) system to evaluate the controlled release of microencapsulated IgY. The microcapsule formulation was optimized as an ALG concentration of 1.56% (15.6 g/L), COS level of 0.61% (6.1 g/L), and IgY/ALG ratio of 62.44% (mass ratio). The microcapsules prepared following this formulation had an encapsulation efficiency of 65.19%, a loading capacity of 33.75%, and an average particle size of 588.75 μm. Under this optimum formulation, the coating of COS provided a less porous and more continuous microstructure by filling the cracks on the surface, and thus the GI release rate of encapsulated IgY was significantly reduced. The release of encapsulated IgY during simulated gastric and intestinal digestion well fitted the zero-order and first-order kinetics functions, respectively. The microcapsule also allowed the IgY to retain 84.37% immune-activity after 4 h simulated GI digestion, significantly higher than that for unprotected IgY (5.33%). This approach could provide an efficient way to preserve IgY and improve its performance in the GI tract.
Collapse
Affiliation(s)
- Jin Zhang
- Institute of Food Science, Zhejiang Academy of Agricultural Sciences, Hangzhou 310021, China.,Zhejiang-Russia Joint R&D Center for Nutritional and Health Food Green Manufacturing, Hangzhou 310021, China
| | - Huan-Huan Li
- Institute of Food Science, Zhejiang Academy of Agricultural Sciences, Hangzhou 310021, China.,Zhejiang-Russia Joint R&D Center for Nutritional and Health Food Green Manufacturing, Hangzhou 310021, China
| | - Yi-Fan Chen
- Institute of Food Science, Zhejiang Academy of Agricultural Sciences, Hangzhou 310021, China.,Zhejiang-Russia Joint R&D Center for Nutritional and Health Food Green Manufacturing, Hangzhou 310021, China
| | - Li-Hong Chen
- Institute of Food Science, Zhejiang Academy of Agricultural Sciences, Hangzhou 310021, China.,Zhejiang-Russia Joint R&D Center for Nutritional and Health Food Green Manufacturing, Hangzhou 310021, China
| | - Hong-Gang Tang
- Institute of Food Science, Zhejiang Academy of Agricultural Sciences, Hangzhou 310021, China.,Zhejiang-Russia Joint R&D Center for Nutritional and Health Food Green Manufacturing, Hangzhou 310021, China
| | - Fan-Bin Kong
- Department of Food Science and Technology, The University of Georgia, Athens GA 30602, USA
| | - Yun-Xin Yao
- Zhejiang AGS Biotech Co., Ltd., Huzhou 313100, China
| | - Xu-Ming Liu
- Beijing Deqingyuan Food Co., Ltd., Beijing 100094, China
| | - Qian Lan
- Collage of Chemistry and Bioengineering, Hunan University of Science and Engineering, Yongzhou 425199, China
| | - Xiao-Fan Yu
- Collage of Chemistry and Bioengineering, Hunan University of Science and Engineering, Yongzhou 425199, China
| |
Collapse
|
9
|
Gu L, McClements DJ, Li J, Su Y, Yang Y, Li J. Formulation of alginate/carrageenan microgels to encapsulate, protect and release immunoglobulins: Egg Yolk IgY. Food Hydrocoll 2021. [DOI: 10.1016/j.foodhyd.2020.106349] [Citation(s) in RCA: 17] [Impact Index Per Article: 5.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/17/2023]
|
10
|
Design and Investigation of Penetrating Mechanism of Octaarginine-Modified Alginate Nanoparticles for Improving Intestinal Insulin Delivery. J Pharm Sci 2020; 110:268-279. [PMID: 32663595 DOI: 10.1016/j.xphs.2020.07.004] [Citation(s) in RCA: 19] [Impact Index Per Article: 4.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/30/2020] [Revised: 07/04/2020] [Accepted: 07/06/2020] [Indexed: 11/24/2022]
Abstract
The aim of the study is to design octaarginine (R8)-modified insulin-alginate nanoparticles (INS-SA/R8 NPs) as the oral insulin delivery system, and further investigate its penetrating mechanism. The characterization results indicated that the surface of INS-SA/R8 NPs was smooth and the average diameter was about 300 nm. INS-SA/R8 NPs exhibited a stronger stability in the simulated gastrointestinal fluids and had a better controlled release than unmodified alginate nanoparticles (INS-SA NPs). Moreover, INS-SA/R8 NPs group had the strongest insulin transport capacity and the largest amount of insulin uptake in all experimental groups. Most importantly, the improvement of insulin intestinal uptake was further confirmed in rat intestine in vivo, and its penetrating mechanism might be involved in the production of endogenous nitric oxide (NO) signal molecule. In addition, in vivo hypoglycemic studies showed that orally administrated INS-SA/R8 NPs produced a better hypoglycemic effect as compared with INS-SA NPs in diabetic rats. Meanwhile, from the cytotoxicity analysis, INS-SA/R8 NPs were safe for oral administration. Taken together, INS-SA/R8 NPs was a good oral insulin delivery system, which might also be suitable for other protein drugs.
Collapse
|
11
|
Yusheng S, Chenjun M, Yingying H, Tiantian W, Liefeng Z. Multifunctional nanoparticles of paclitaxel and cyclodextrin-polypeptide conjugates with in vitro anticancer activity. Pharm Dev Technol 2020; 25:1071-1080. [PMID: 32589088 DOI: 10.1080/10837450.2020.1787441] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/29/2022]
Abstract
In this study, the cyclodextrin polypeptide (R8-CMβCD) was successfully synthesized by the conjugation of a cell-penetrating peptide (R8) with carboxymethyl-β-cyclodextrin (CMβCD) via the carbon diamine reaction. Then, paclitaxel-loaded nanoparticles (PTX@R8-CMβCD NPs) was prepared. Results of transmission electron microscopy (TEM) showed that PTX@R8-CMβCD NPs were spherical with smooth surfaces and an average diameter about 144 nm. The amount of PTX released from NPs was less than 20% at pH7.4, but it increased significantly to 80% in the weakly acidic cytoplasm of tumors (pH5.0). Furthermore, PTX@R8-CMβCD NPs promoted the cellular uptake of PTX. Further studies on the mechanism showed that cellular uptake of PTX@R8-CMβCD NPs could rely on multiple pathways. In addition, the NPs had the ability to inhibit P-gp efflux pumps. Cytotoxicity tests showed that the NPs had no side effects. Taken together, PTX@R8-CMβCD NPs is an effective anticancer drug delivery system, and the material (R8-CMβCD) may be a promising anti-cancer drug carrier.
Collapse
Affiliation(s)
- Sun Yusheng
- School of Food Science and Pharmaceutical Engineering, Nanjing Normal University, Nanjing, China
| | - Ma Chenjun
- School of Food Science and Pharmaceutical Engineering, Nanjing Normal University, Nanjing, China
| | - Hua Yingying
- School of Food Science and Pharmaceutical Engineering, Nanjing Normal University, Nanjing, China
| | - Wei Tiantian
- School of Food Science and Pharmaceutical Engineering, Nanjing Normal University, Nanjing, China
| | - Zhang Liefeng
- School of Food Science and Pharmaceutical Engineering, Nanjing Normal University, Nanjing, China
| |
Collapse
|
12
|
Layek B, Mandal S. Natural polysaccharides for controlled delivery of oral therapeutics: a recent update. Carbohydr Polym 2020; 230:115617. [DOI: 10.1016/j.carbpol.2019.115617] [Citation(s) in RCA: 50] [Impact Index Per Article: 12.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/06/2019] [Revised: 11/11/2019] [Accepted: 11/12/2019] [Indexed: 11/28/2022]
|
13
|
Severino P, da Silva CF, Andrade LN, de Lima Oliveira D, Campos J, Souto EB. Alginate Nanoparticles for Drug Delivery and Targeting. Curr Pharm Des 2019; 25:1312-1334. [PMID: 31465282 DOI: 10.2174/1381612825666190425163424] [Citation(s) in RCA: 98] [Impact Index Per Article: 19.6] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/18/2019] [Accepted: 04/15/2019] [Indexed: 12/31/2022]
Abstract
Nanotechnology refers to the control, manipulation, study and manufacture of structures and devices at the nanometer size range. The small size, customized surface, improved solubility and multi-functionality of nanoparticles will continue to create new biomedical applications, as nanoparticles allow to dominate stability, solubility and bioavailability, as well controlled release of drugs. The type of a nanoparticle, and its related chemical, physical and morphological properties influence its interaction with living cells, as well as determine the route of clearance and possible toxic effects. This field requires cross-disciplinary research and gives opportunities to design and develop multifunctional devices, which allow the diagnosis and treatment of devastating diseases. Over the past few decades, biodegradable polymers have been studied for the fabrication of drug delivery systems. There was extensive development of biodegradable polymeric nanoparticles for drug delivery and tissue engineering, in view of their applications in controlling the release of drugs, stabilizing labile molecules from degradation and site-specific drug targeting. The primary aim is to reduce dosing frequency and prolong the therapeutic outcomes. For this purpose, inert excipients should be selected, being biopolymers, e.g. sodium alginate, commonly used in controlled drug delivery. Nanoparticles composed of alginate (known as anionic polysaccharide widely distributed in the cell walls of brown algae which, when in contact with water, forms a viscous gum) have emerged as one of the most extensively characterized biomaterials used for drug delivery and targeting a set of administration routes. Their advantages include not only the versatile physicochemical properties, which allow chemical modifications for site-specific targeting but also their biocompatibility and biodegradation profiles, as well as mucoadhesiveness. Furthermore, mechanical strength, gelation, and cell affinity can be modulated by combining alginate nanoparticles with other polymers, surface tailoring using specific targeting moieties and by chemical or physical cross-linking. However, for every physicochemical modification in the macromolecule/ nanoparticles, a new toxicological profile may be obtained. In this paper, the different aspects related to the use of alginate nanoparticles for drug delivery and targeting have been revised, as well as how their toxicological profile will determine the therapeutic outcome of the drug delivery system.
Collapse
Affiliation(s)
- Patricia Severino
- Universidade Tiradentes (Unit), Av. Murilo Dantas, 300, Farolandia, Aracaju-SE, CEP 49.032-490, Brazil
- Instituto de Tecnologia e Pesquisa, Laboratório de Nanotecnologia e Nanomedicina (LNMed) Av. Murilo Dantas, 300, Aracaju - SE, CEP 49.032-490, Brazil
| | - Classius F da Silva
- Universidade Federal de Sao Paulo, Instituto de Ciências Ambientais, Quimicas e Farmaceuticas, Departamento de Engenharia Quimica, Rua Sao Nicolau, 210, Diadema - SP, CEP 09.913-030, Brazil
| | - Luciana N Andrade
- Universidade Tiradentes (Unit), Av. Murilo Dantas, 300, Farolandia, Aracaju-SE, CEP 49.032-490, Brazil
- Instituto de Tecnologia e Pesquisa, Laboratório de Nanotecnologia e Nanomedicina (LNMed) Av. Murilo Dantas, 300, Aracaju - SE, CEP 49.032-490, Brazil
| | - Daniele de Lima Oliveira
- Universidade Tiradentes (Unit), Av. Murilo Dantas, 300, Farolandia, Aracaju-SE, CEP 49.032-490, Brazil
- Instituto de Tecnologia e Pesquisa, Laboratório de Nanotecnologia e Nanomedicina (LNMed) Av. Murilo Dantas, 300, Aracaju - SE, CEP 49.032-490, Brazil
| | - Joana Campos
- Department of Pharmaceutical Technology, Faculty of Pharmacy, University of Coimbra (FFUC), Polo das Ciencias da Saude, Azinhaga de Santa Comba, 3000-548 Coimbra, Portugal
| | - Eliana B Souto
- Department of Pharmaceutical Technology, Faculty of Pharmacy, University of Coimbra (FFUC), Polo das Ciencias da Saude, Azinhaga de Santa Comba, 3000-548 Coimbra, Portugal
- CEB - Centre of Biological Engineering, University of Minho, Campus de Gualtar 4710-057 Braga, Portugal
| |
Collapse
|
14
|
Affiliation(s)
- Wahid Khan
- Department of PharmaceuticsNational Institute of Pharmaceutical Education & Research (NIPER) Hyderabad 500037 India
| | - Ester Abtew
- School of Pharmacy-Faculty of MedicineThe Hebrew University of Jerusalem Jerusalem 91120 Israel
| | - Sheela Modani
- Department of PharmaceuticsNational Institute of Pharmaceutical Education & Research (NIPER) Hyderabad 500037 India
| | - Abraham J. Domb
- School of Pharmacy-Faculty of MedicineThe Hebrew University of Jerusalem Jerusalem 91120 Israel
| |
Collapse
|
15
|
Palmieri V, Bugli F, Cacaci M, Perini G, Maio FD, Delogu G, Torelli R, Conti C, Sanguinetti M, Spirito MD, Zanoni R, Papi M. Graphene oxide coatings prevent Candida albicans biofilm formation with a controlled release of curcumin-loaded nanocomposites. Nanomedicine (Lond) 2018; 13:2867-2879. [PMID: 30431405 DOI: 10.2217/nnm-2018-0183] [Citation(s) in RCA: 39] [Impact Index Per Article: 6.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/13/2022] Open
Abstract
AIM Fabrication of graphene oxide (GO)-based medical devices coatings that limit adhesion of Candida albicans, a main issue of healthcare-associated infections. METHODS The GO composites noncovalently functionalized with curcumin (CU), a hydrophobic molecule with active antimicrobial action, polyethylene glycol (PEG) that hinders the absorption of biomolecules or a combination of CU and PEG (GO-CU-PEG) were drop-casted on surfaces and antifungal efficacy was assessed. RESULTS We demonstrate that GO-CU-PEG coatings can reduce fungal adhesion, proliferation and biofilm formation. Furthermore, in an aqueous environment, surfaces release curcumin-PEG nanocomposites that have a minimum inhibitory concentration of 9.25 μg/ml against C. albicans. CONCLUSION Prevention of early cell adhesion and creation of a proximal environment unfavorable for growth make these GO-supported biomaterials attractive for innovative medical device manufacturing.
Collapse
Affiliation(s)
- Valentina Palmieri
- Fondazione Policlinico A. Gemelli IRCCS - Università Cattolica Sacro Cuore. Istituto di Fisica, Largo Francesco Vito 1, 00168, Rome, Italy.,Institute for Complex Systems, National Research Council (ISC-CNR), Via dei Taurini 19, 00185 Rome, Italy
| | - Francesca Bugli
- Fondazione Policlinico A. Gemelli IRCCS - Università Cattolica Sacro Cuore. Istituto di Microbiologia, Largo Francesco Vito 1, 00168, Rome, Italy
| | - Margherita Cacaci
- Fondazione Policlinico A. Gemelli IRCCS - Università Cattolica Sacro Cuore. Istituto di Microbiologia, Largo Francesco Vito 1, 00168, Rome, Italy
| | - Giordano Perini
- Fondazione Policlinico A. Gemelli IRCCS - Università Cattolica Sacro Cuore. Istituto di Fisica, Largo Francesco Vito 1, 00168, Rome, Italy
| | - Flavio De Maio
- Fondazione Policlinico A. Gemelli IRCCS - Università Cattolica Sacro Cuore. Istituto di Microbiologia, Largo Francesco Vito 1, 00168, Rome, Italy
| | - Giovanni Delogu
- Fondazione Policlinico A. Gemelli IRCCS - Università Cattolica Sacro Cuore. Istituto di Microbiologia, Largo Francesco Vito 1, 00168, Rome, Italy
| | - Riccardo Torelli
- Fondazione Policlinico A. Gemelli IRCCS - Università Cattolica Sacro Cuore. Istituto di Microbiologia, Largo Francesco Vito 1, 00168, Rome, Italy
| | - Claudio Conti
- Institute for Complex Systems, National Research Council (ISC-CNR), Via dei Taurini 19, 00185 Rome, Italy
| | - Maurizio Sanguinetti
- Fondazione Policlinico A. Gemelli IRCCS - Università Cattolica Sacro Cuore. Istituto di Microbiologia, Largo Francesco Vito 1, 00168, Rome, Italy
| | - Marco De Spirito
- Fondazione Policlinico A. Gemelli IRCCS - Università Cattolica Sacro Cuore. Istituto di Fisica, Largo Francesco Vito 1, 00168, Rome, Italy
| | - Robertino Zanoni
- Dipartimento di Chimica, Università di Roma La Sapienza, Piazzale Aldo Moro 5, 00185 Rome, Italy
| | - Massimiliano Papi
- Fondazione Policlinico A. Gemelli IRCCS - Università Cattolica Sacro Cuore. Istituto di Fisica, Largo Francesco Vito 1, 00168, Rome, Italy
| |
Collapse
|